Interview: Michel van Agthoven – Chair of the Pharmaceutical Committee (Access Team), The American Chamber of Commerce in the Netherlands
30.10.2015
Related Interviews
Daara Patel – Secretary General, Indian Drug Manufacturers’ Association…
The IDMA’s Daara Patel outlines the association’s role in representing the diverse voices of the Indian pharmaceutical sector, advocating for manufacturers of all sizes. He explores the challenges and initiatives…
Maria do Carmo Neves – President, APOGEN
Erstwhile 21-year CEO of leading Portuguese generics group Tecnimede, Maria do Carmo Neves today serves as president of her country’s generics industry association, APOGEN. She outlines the highly challenging market…
Sudarshan Jain – Secretary General, Indian Pharmaceutical Alliance (IPA)
As secretary general of the Indian Pharmaceutical Alliance (IPA) Sudarshan Jain represents the interests of 25 leading Indian pharmaceutical companies, both at home and abroad. He outlines the association’s focus…
Algeria / Pharma & Healthcare: 5 Things to Know
With a healthcare system marked by both progress and difficulties due to the country’s economic overreliance on the oil and gas sector and its recent political instability, Algeria, is the…
Digital Transformation / 3 Insights from UCB CEO Jean-Christophe Tellier
UCB has been undergoing a far-reaching digital business transformation, integrating novel approaches across its R&D organisation, including Computer-Aided Drug Design (CADD) and AI, while striving to maintain a patient-centric focus.…
Germany / Bayer's Latest Woes; New EUR 2 bln Lilly Plant; Boehringer Ingelheim's T3 Pharma Acquisition
The latest pharma industry news from Germany, including Lilly’s new German plant; Bayer’s aborted anti-clotting drug trial and legal worries; Boehringer Ingelheim’s acquisition of Swiss biotech T3 Pharmaceuticals, and Hermes…
